[[abstract]]We used the Transwell system to select highly invasive cell lines from minimally invasive parent cells, and we compared gene expression in paired cell lines with high and low invasive potentials. AxI was relatively overexpressed in the highly invasive cell lines when compared with their minimally invasive counterparts. However, there is only limited information about the role of AxI in cancer invasion. The biologic function of AxI in tumor invasion was investigated by overexpression of full-length AxI in minimally invasive cells and by siRNA knockdown of AxI expression in highly invasive cells. Overexpression of AxI in minimally invasive cells increased their invasiveness. siRNA reduced cell invasiveness as AxI was downregulated...
IntroductionAcquired cancer therapy resistance evolves under selection pressure of immune surveillan...
Introduction Acquired cancer therapy resistance evolves under selection pressure of immune surveill...
Head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge and identification of nov...
[[abstract]]We used the Transwell system to select highly invasive cell lines from minimally invasiv...
We used the Transwell system to select highly invasive cell lines from minimally invasive parent cel...
AbstractWe used the Transwell system to select highly invasive cell lines from minimally invasive pa...
We used the Transwell system to select highly invasive cell lines from minimally invasive parent cel...
AbstractWe used the Transwell system to select highly invasive cell lines from minimally invasive pa...
The receptor tyrosine kinase AXL is a member of the Tyro3-Axl-Mer receptor tyrosine kinase subfamily...
Abstract Axl receptor tyrosine kinase is involved in the growth and metastasis and is an indicator o...
[[abstract]]Background: Overexpression of the receptor tyrosine kinase Axl is implicated in several ...
[[abstract]]Background: Overexpression of the receptor tyrosine kinase Axl is implicated in several ...
Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic fo...
IntroductionAcquired cancer therapy resistance evolves under selection pressure of immune surveillan...
AXL receptor tyrosine kinase is overexpressed in esophageal adenocarcinoma (EAC) and several other t...
IntroductionAcquired cancer therapy resistance evolves under selection pressure of immune surveillan...
Introduction Acquired cancer therapy resistance evolves under selection pressure of immune surveill...
Head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge and identification of nov...
[[abstract]]We used the Transwell system to select highly invasive cell lines from minimally invasiv...
We used the Transwell system to select highly invasive cell lines from minimally invasive parent cel...
AbstractWe used the Transwell system to select highly invasive cell lines from minimally invasive pa...
We used the Transwell system to select highly invasive cell lines from minimally invasive parent cel...
AbstractWe used the Transwell system to select highly invasive cell lines from minimally invasive pa...
The receptor tyrosine kinase AXL is a member of the Tyro3-Axl-Mer receptor tyrosine kinase subfamily...
Abstract Axl receptor tyrosine kinase is involved in the growth and metastasis and is an indicator o...
[[abstract]]Background: Overexpression of the receptor tyrosine kinase Axl is implicated in several ...
[[abstract]]Background: Overexpression of the receptor tyrosine kinase Axl is implicated in several ...
Abstract To study the role of cell softening in malignant progression, Transwell assay and atomic fo...
IntroductionAcquired cancer therapy resistance evolves under selection pressure of immune surveillan...
AXL receptor tyrosine kinase is overexpressed in esophageal adenocarcinoma (EAC) and several other t...
IntroductionAcquired cancer therapy resistance evolves under selection pressure of immune surveillan...
Introduction Acquired cancer therapy resistance evolves under selection pressure of immune surveill...
Head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge and identification of nov...